EUVIMEDEUVIMED entdecken
Open Access

Sustained dual delivery of metronidazole and viable Lactobacillus crispatus from 3D-printed silicone shells

Anthony J Kyser, Mohamed Y Mahmoud, Bassam Fotouh, Rudra Patel, Christy Armstrong, Marnie Aagard, Isaiah Rush, Warren Lewis, Amanda Lewis, Hermann B Frieboes

Biomaterials Advances · 2024

DOI: 10.1016/j.bioadv.2024.214005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomaterials Advances, 2024. Verfasst von Anthony J Kyser und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, University of Louisville, Louisville, KY, USA. Hauptthemen laut MEDLINE: Printing, Three-Dimensional, Silicones, Metronidazole, Probiotics. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institutes of Health, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bacterial vaginosis (BV) is an imbalance of the vaginal microbiome in which there are limited lactobacilli and an overgrowth of anaerobic and fastidious bacteria such as Gardnerella. The propensity for BV recurrence is high, and therapies involving multiple treatment modalities are emerging to meet this need. However, current treatments requiring frequent therapeutic administration are challenging for patients and impact user compliance. Three-dimensional (3D)-printing offers a novel alternative to customize platforms to facilitate sustained therapeutic delivery to the vaginal tract. This study designed a novel vehicle intended for dual sustained delivery of both antibiotic and probiotic. 3D-printed compartmental scaffolds consisting of an antibiotic-containing silicone shell and a core containing probiotic Lactobacillus were developed with multiple formulations including biomaterials sodium alginate (SA), polyethylene glycol (PEG), polyvinyl alcohol (PVA), polyethylene oxide (PEO), and kappa-carrageenan (KC). The vehicles were loaded with 50 μg of metronidazole/mg polymer and 5 × 107 CFU of L. crispatus/mg scaffold. Metronidazole-containing shells exhibited cumulative drug release of 324.2 ± 31.2 μg/mL after 14 days. Multiple polymeric formulations for the probiotic core demonstrated cumulative L. crispatus recovery of >5 × 107 CFU/mg scaffold during this timeframe. L. crispatus-loaded polymeric formulations exhibited ≥2 log CFU/mL reduction in free Gardnerella in the presence of VK2/E6E7 vaginal epithelial cells. As a first step towards the goal of facilitating patient compliance, this study demonstrates in vitro effect of a novel 3D-printed dual antibiotic and probiotic delivery platform to target BV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Printing, Three-DimensionalSiliconesMetronidazoleProbioticsLactobacillus crispatusHumansFemaleVaginosis, BacterialAnti-Bacterial AgentsDelayed-Action PreparationsDrug LiberationDrug Delivery Systems

Stichwörter der Autor:innen

3D-printingAntibioticsBacterial vaginosisLactobacillusProbioticsVaginal drug delivery

Substanzen

SiliconesMetronidazoleAnti-Bacterial AgentsDelayed-Action Preparations

Autor:innen und Institutionen

  • Department of Bioengineering, University of Louisville, Louisville, KY, USA.
  • Department of Bioengineering, University of Louisville, Louisville, KY, USA; Department of Toxicology and Forensic Medicine, Faculty of Veterinary Medicine, Cairo University, Egypt.
  • Glycobiology Research and Training Center, University of California San Diego, La Jolla, CA, USA; Department of Obstetrics, Gynecology and Reproductive Sciences, University of California San Diego, La Jolla, CA, USA.
  • Department of Chemical Engineering, University of Dayton, Dayton, OH, USA.
  • Department of Bioengineering, University of Louisville, Louisville, KY, USA; Center for Predictive Medicine, University of Louisville, Louisville, KY, USA; Department of Pharmacology and Toxicology, University of Louisv…

Förderung

  • NIAID NIH HHS
  • National Institutes of Health
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Kyser, A. J., Mahmoud, M. Y., Fotouh, B., Patel, R., Armstrong, C., Aagard, M., Rush, I., Lewis, W., Lewis, A., & Frieboes, H. B. (2024). Sustained dual delivery of metronidazole and viable Lactobacillus crispatus from 3D-printed silicone shells. Biomaterials Advances. https://doi.org/10.1016/j.bioadv.2024.214005

Vancouver

Kyser AJ, Mahmoud MY, Fotouh B, Patel R, Armstrong C, Aagard M, et al. Sustained dual delivery of metronidazole and viable Lactobacillus crispatus from 3D-printed silicone shells. Biomaterials Advances. 2024. doi:10.1016/j.bioadv.2024.214005

BibTeX
@article{Kyser2024,
  author = {Kyser, Anthony J and Mahmoud, Mohamed Y and Fotouh, Bassam and Patel, Rudra and Armstrong, Christy and Aagard, Marnie and Rush, Isaiah and Lewis, Warren and Lewis, Amanda and Frieboes, Hermann B},
  title = {Sustained dual delivery of metronidazole and viable Lactobacillus crispatus from 3D-printed silicone shells},
  journal = {Biomaterials Advances},
  year = {2024},
  doi = {10.1016/j.bioadv.2024.214005}
}
Kostenlos starten →